Cargando…

Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period

PURPOSE: The standard recall period for the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®) is the past 7 days, but there are contexts where a 24-hour recall may be desirable. The purpose of this analysis was to investigate the reliability and val...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, M. K., Basch, E., Mitchell, S. A., Minasian, L. M., Langlais, B. T., Thanarajasingam, G., Ginos, B. F., Rogak, L. J., Mendoza, T. R., Bennett, A. V., Schrag, D., Mazza, G. L., Dueck, A. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241696/ https://www.ncbi.nlm.nih.gov/pubmed/36897529 http://dx.doi.org/10.1007/s11136-023-03374-5

Ejemplares similares

Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2
por: Mazza, Gina L., et al.
Publicado: (2021)

Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2
por: Mazza, Gina L., et al.
Publicado: (2021)

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
por: Bennett, Antonia V., et al.
Publicado: (2016)

Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE(®) to Provide Two Distinct and Complementary Perspectives
por: Minasian, Lori M, et al.
Publicado: (2022)

Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events
por: Atkinson, Thomas M., et al.
Publicado: (2018)

Score equivalence of paper-, tablet-, and interactive voice response system-based versions of PROMIS, PRO-CTCAE, and numerical rating scales among cancer patients
por: Lee, Minji K., et al.
Publicado: (2021)

Development of a keyword library for capturing PRO-CTCAE-focused “symptom talk” in oncology conversations
por: Durieux, Brigitte N, et al.
Publicado: (2023)

A toolbox of different approaches to analyze and present PRO-CTCAE data in oncology studies
por: Regnault, Antoine, et al.
Publicado: (2023)

Japanese translation and linguistic validation of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
por: Miyaji, Tempei, et al.
Publicado: (2017)

Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2021)

Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Danish prostate cancer patients
por: Baeksted, Christina, et al.
Publicado: (2017)

Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®)
por: Caminiti, Caterina, et al.
Publicado: (2022)

Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
por: Schaffer, Elisabeth M, et al.
Publicado: (2021)

Swahili translation and cultural adaptation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Schroeder, Kristin M., et al.
Publicado: (2023)

The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events
por: Kawaguchi, Takashi, et al.
Publicado: (2018)

Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Lee, Minji K., et al.
Publicado: (2020)

Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Lee, Minji K., et al.
Publicado: (2021)

Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Lee, Minji K., et al.
Publicado: (2023)

Dutch translation and linguistic validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
por: Veldhuijzen, Evalien, et al.
Publicado: (2020)

Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure
por: Feldman, E., et al.
Publicado: (2023)

Developing tumor-specific PRO-CTCAE item sets: analysis of a cross-sectional survey in three German outpatient cancer centers
por: Günther, Maximilian, et al.
Publicado: (2023)

A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy
por: Christiansen, Mille Guldager, et al.
Publicado: (2023)

Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial
por: Lee, Mangyeong, et al.
Publicado: (2023)

The use of and adherence to CTCAE v3.0 in cancer clinical trial publications
por: Zhang, Sheng, et al.
Publicado: (2016)

Linguistic validation of the simplified Chinese version of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)
por: KKF, Cheng, et al.
Publicado: (2020)

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
por: Wang, Tian Qi, et al.
Publicado: (2018)

Software for Administering the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study
por: Schoen, Martin W, et al.
Publicado: (2018)

Daily calcium intake in male children and adolescents obtained from the rapid assessment method and the 24-hour recall method
por: Moore, Michael, et al.
Publicado: (2007)

Validation of a Modified Version of the Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom Score
por: Langlais, Blake T., et al.
Publicado: (2021)

P1730: IMPLEMENTATION OF PRO-CTCAE QUESTIONNAIRE IN PROM PROGRAM COLLECTS DIFFERENT ADVERSE EVENTS PROFILE THAN PHYSICIANS AND REDUCE UNSCHEDULED HEALTHCARE IN PATIENTS WITH LYMPHOMA RECEIVING IV THERAPY
por: RAMOS, S., et al.
Publicado: (2022)

Agreement between 24-hour urine and 24-hour food recall in measuring salt intake in primary school children in Australia
por: Santos, Joseph Alvin, et al.
Publicado: (2022)

Multicenter Prospective Cohort Study of the Patient-Reported Outcome Measures PRO-CTCAE and CAT EORTC QLQ-C30 in Major Abdominal Cancer Surgery (PATRONUS): A Student-Initiated German Medical Audit (SIGMA) Study
por: Mihaljevic, André L.
Publicado: (2021)

Limitations of 24-hour Recall Method: Micronutrient Intake and the Presence of the Metabolic Syndrome
por: Raina, Sunil Kumar
Publicado: (2013)

Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care
por: Langlais, Blake T., et al.
Publicado: (2020)

How Accurately Can We Recall the Timing of Food Intake? A Comparison of Food Times from Recall-Based Survey Questions and Daily Food Records
por: Gioia, Siena C, et al.
Publicado: (2022)

A New Statistical Method for Estimating Usual Intakes of Nearly-Daily Consumed Foods and Nutrients Through Use of Only One 24-hour Dietary Recall
por: Luo, Hanqi, et al.
Publicado: (2019)

Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats
por: LeBlanc, Amy K., et al.
Publicado: (2021)

THU513 Are Endocrinologists Using CTCAE Grading System For Endocrine Side Effects Of Cancer Treatment With Immune Checkpoint Inhibitors?
por: Arnouk, Nelly, et al.
Publicado: (2023)

Nutrient Estimation from 24-Hour Food Recalls Using Machine Learning and Database Mapping: A Case Study with Lactose
por: Chin, Elizabeth L., et al.
Publicado: (2019)

Exclusive Breastfeeding Rates and Factors Associated with Exclusive Breastfeeding Practices in Northern Tanzania: Measurement using Two Different Methodologies—24 Hours Recall and Recall Since Birth
por: Hussein, Tamara H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_egru8oagsgftlgl0769sctetui